Roth Capital lowered the firm’s price target on Hyster-Yale (HY) to $40 from $50 and keeps a Buy rating on the shares after its Q3 results. Conditions stay challenging given the impact of market uncertainties and tariffs on both customer decision-making and underlying product profitability, as forward visibility looks much more limited currently, the analyst tells investors in a research note.
Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on HY:
